A press release distributed through ABNewswire announces the launch of NextWave Peptides, a U.S.-based online research peptide catalog built, the company says, around making analytical documentation easier to match to a specific product and lot. The Los Angeles company says it serves independent researchers, academic institutions, and private laboratories.

A Certificate of Analysis, or COA, is the lab document that records what a vial was tested for and what the test found. The pitch here is that each catalog listing connects to a dedicated COA Library organized by product and lot, so a buyer can confirm that a given document actually applies to the vial in front of them rather than to a different batch entirely.

The lot-matching problem is real

Anyone who has shopped this market knows the failure mode NextWave is describing. A company spokesperson identified only as Jam says catalogs get hard to navigate when similar abbreviations, multiple strengths, package quantities, and analytical documents sit on unrelated pages, and that is a fair description of most research peptide storefronts.

The company says its quality framework starts with a 99%+ analytical purity standard supported by independent third-party testing. Notably, the release does not treat that number as the headline: Jam says a 99%+ result is meaningful only when the method, product, and lot are clear, and that HPLC purity and mass-based identity information answer different questions.

What the release does not say

It does not name the third-party lab. It does not say which products the COA Library currently covers, how many listings are live, or whether every lot in the catalog has a matching record, and no outside auditor or trade body is cited anywhere in the announcement.

Fulfillment runs through a U.S. warehouse with dispatch within 24 hours and standard delivery typically taking 3 to 8 days after processing, subject to carrier conditions. The storefront also offers a free reconstitution calculator that converts vial content and diluent volume into a concentration, which is a routine lab tool and also, candidly, a sales aid.

Bottom line

This is a company announcement, not an independent assessment, and ABNewswire attaches its own disclaimer to the content. NextWave states its products are intended exclusively for lawful laboratory research and not for human or veterinary use.